Therefore, we confirmed that PLEKHH2 promotes the activity of the PI3K/AKT signaling pathway by promoting FAK phosphorylation, which then confers a malignant phenotype in lung cancer cells. Here, PLEKHH2 is linked to lung carcinoma.